Received May 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | X012281 | — |
No additional AE; Customer calling to report that a dose of VARIVAX was administered after its expiration date.; Information has been received from Business Partner/CRO on 02-May-2025. This spontaneous report was received from a/an Other health professional and refers to a(n) patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE), (lot #X012281, expiration date: 30-Apr-2025). On an unknown date, the patient started therapy with sterile diluent (BAXTER STERILE DILUENT), (lot # and expiration date were not reported). The patient started therapy with sterile diluent (BAXTER STERILE DILUENT), for the treatment of Prophylaxis. The patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE), for the treatment of Prophylaxis. On 01-May-2025, the patient experienced Customer calling to report that a dose of VARIVAX was administered after its expiration date.. On an unknown date, the patient experienced No additional AE. At the reporting time, the outcome of No additional AE and Customer calling to report that a dose of VARIVAX was administered after its expiration date. was unknown. The action taken with sterile diluent and Varicella Virus Vaccine Live (Oka-Merck) was reported as not applicable.
Sterile diluent